FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome
FBXO11是骨髓增生异常综合征白血病转化过程中的候选抑癌基因。
期刊:Blood Cancer Journal
影响因子:12.9
doi:10.1038/s41408-020-00362-7.
Michael Schieber ,Christian Marinaccio ,Lyndsey C Bolanos ,Wendy D Haffey ,Kenneth D Greis ,Daniel T Starczynowski ,John D Crispino